Drug discovery is a notoriously expensive and time-consuming undertaking, with the process of finding a viable molecule often stretching over a decade and costing billions, while most candidates still fail to reach the market. Many AI startups have emerged, aiming to alleviate this burden, but they tend to cater to researchers who already possess sophisticated […]
In a recent policy paper, former Google CEO Eric Schmidt, Scale AI CEO Alexandr Wang, and Center for AI Safety Director Dan Hendrycks caution against the U.S. pursuing a Manhattan Project-style initiative to develop Artificial General Intelligence (AGI), which represents superhuman intelligence. They argue that an aggressive quest for control over superintelligent AI could incite […]